Search
for

    Sort by

    Research 30 of 38

    1. Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study Journal of Clinical and Diagnostic Research · 2023
    2. Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint) JMIR Dermatology · 2025
    3. Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint) 2025
    4. Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia Clinical, Cosmetic and Investigational Dermatology · 2023
    5. Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study DIGITAL HEALTH · 2023
    6. Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States Advances in Therapy · 2022 · 7 citations
    7. Digital health platforms expand access and improve care for male androgenetic alopecia International Journal of Dermatology · 2022
    8. Factors influencing alopecia areata treatment decisions: A qualitative assessment JAAD International · 2022 · 9 citations
    9. Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging Dermatology Online Journal · 2026
    10. Local Corticosteroids for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025 · 8 citations
    11. Association Between Natural Hair Color, Race, and Alopecia Dermatology and Therapy · 2024
    12. A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix 2011 · 3 citations
    13. Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata Dermatology and Therapy · 2025
    14. Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year Journal of the European Academy of Dermatology and Venereology · 2024
    15. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 · 25 citations
    16. Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2 Annales de dermatologie et de vénéréologie, FMC · 2023
    17. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies Journal of the American Academy of Dermatology · 2024 · 2 citations
    18. Evaluation of Stigma Toward Individuals With Alopecia JAMA Dermatology · 2021 · 38 citations
    19. The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata Dermatology and Therapy · 2022 · 29 citations
    20. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    21. Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study Journal of The American Academy of Dermatology · 2021 · 2 citations
    22. Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment Journal of Dermatological Treatment · 2026
    23. Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review Dermatology and Therapy · 2021 · 67 citations
    24. Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA Dermatology and Therapy · 2026
    25. Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA) SKIN The Journal of Cutaneous Medicine · 2025
    26. Shock Wave Therapy for Erectile Dysfunction: Marketing and Practice Trends in Major Metropolitan Areas in the United States Urology Practice · 2022 · 8 citations
    27. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials JEADV Clinical Practice · 2023
    28. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population JAMA Dermatology · 2023 · 75 citations
    29. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials Journal of dermatological treatment · 2023 · 3 citations
    30. Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States Journal of Medical Economics · 2023 · 3 citations